Preview

Articles in the January issue of Health Affairs discussed health inequities related to dental care use, geographic proximity to providers, physician obligations to patients with disabilities, and insurance enrollment.

George Wehby and coauthors analyzed national survey data and found that Medicaid expansion in states where extensive adult dental benefits were included saw a narrowing of racial and ethnic disparities in dental care use in low-income adults.

Dimitris Karletsos and Charles Stoecker examined changes in the geographic proximity of Medicaid enrollees to providers in the wake of Louisiana’s 2016 Medicaid expansion.

They determined that distance traveled by Medicaid beneficiaries decreased across all eight types of services examined, with the greatest declines seen among Black residents of nonmetropolitan areas for general practice.

Lisa Iezzoni and coauthors surveyed physicians across the US to examine the extent to which they understood their obligations to patients with disabilities under the Americans with Disabilities Act (ADA). In their findings, they reported that 35.8 percent of those surveyed reported knowing little or nothing about their responsibilities under the ADA.

Toward the end of the open enrollment period in California’s Affordable Care Act Marketplace, Covered California, tens of thousands of people begin but do not complete the enrollment process.

Rebecca Myerson and coauthors reported results from a randomized trial showing that personalized telephone calls from service center representatives to discuss consumers’ options increased enrollment for lower-income households, with particularly large increases seen among adults older than age fifty.

Today in Health Affairs Forefront, David Lansky argues that to ensure care is more patient-focused, we need profound changes in how we capture and apply information about quality of care and health outcomes.

Sean Tunis and coauthors explain that the Centers for Medicare and Medicaid Services’ (CMS’) draft national coverage decision on monoclonal antibody therapies for the treatment of Alzheimer’s disease highlights the difference in decision-making authorities between the Food and Drug Administration and CMS.

Kathryn Phillips and Rita Redberg discuss key policy implications of CMS’ recent decision on Alzheimer’s drugs, including the role of “coverage with evidence development.”

Advertise with Health Affairs this month to take advantage of our current promotions. Learn more about advertising opportunities here.

About Health Affairs

Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.

Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States

Privacy Policy

To unsubscribe from this email, click here.